Trial Profile
Examination for the effect of combination therapy using SERM and Eldecalcitol for the patients with osteoporosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary) ; Alfacalcidol; Raloxifene
- Indications Osteoporosis
- Focus Therapeutic Use
- 27 Jul 2011 New trial record